JULIE BOOM to Female
This is a "connection" page, showing publications JULIE BOOM has written about Female.
Connection Strength
0.251
-
Arboviral Surveillance among Pediatric Patients with Acute Febrile Illness in Houston, Texas. Am J Trop Med Hyg. 2018 08; 99(2):413-416.
Score: 0.018
-
Prevalence of Vaccine Hesitancy Among Expectant Mothers in Houston, Texas. Acad Pediatr. 2018 03; 18(2):154-160.
Score: 0.017
-
Understanding the Financial Implications of Immunization Reminder/Recall in a Multipractice Pediatric Group. Acad Pediatr. 2017 04; 17(3):323-329.
Score: 0.016
-
Parental report of vaccine receipt in children with autism spectrum disorder: Do rates differ by pattern of ASD onset? Vaccine. 2016 Mar 08; 34(11):1335-42.
Score: 0.016
-
Variation in rotavirus vaccine coverage by provider location and subsequent disease burden. Pediatrics. 2015 Feb; 135(2):e432-9.
Score: 0.015
-
The Texas Children's Hospital immunization forecaster: conceptualization to implementation. Am J Public Health. 2014 Dec; 104(12):e65-71.
Score: 0.014
-
Symptomatic infection and detection of vaccine and vaccine-reassortant rotavirus strains in 5 children: a case series. J Infect Dis. 2012 Oct; 206(8):1275-9.
Score: 0.012
-
Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics. 2010 Feb; 125(2):e199-207.
Score: 0.010
-
Maternal Vaccine Effectiveness Against Influenza-Associated Hospitalizations and Emergency Department Visits in Infants. JAMA Pediatr. 2024 Feb 01; 178(2):176-184.
Score: 0.007
-
Effectiveness of Maternal mRNA COVID-19 Vaccination During Pregnancy Against COVID-19-Associated Hospitalizations in Infants Aged <6 Months During SARS-CoV-2 Omicron Predominance - 20 States, March 9, 2022-May 31, 2023. MMWR Morb Mortal Wkly Rep. 2023 Sep 29; 72(39):1057-1064.
Score: 0.007
-
Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants. N Engl J Med. 2022 07 14; 387(2):109-119.
Score: 0.006
-
Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19-Associated Hospitalization in Infants Aged <6 Months - 17 States, July 2021-January 2022. MMWR Morb Mortal Wkly Rep. 2022 Feb 18; 71(7):264-270.
Score: 0.006
-
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021. MMWR Morb Mortal Wkly Rep. 2022 Jan 14; 71(2):52-58.
Score: 0.006
-
Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents. N Engl J Med. 2022 02 24; 386(8):713-723.
Score: 0.006
-
Characteristics and Clinical Outcomes of Children and Adolescents Aged <18 Years Hospitalized with COVID-19 - Six Hospitals, United States, July-August 2021. MMWR Morb Mortal Wkly Rep. 2021 12 31; 70(5152):1766-1772.
Score: 0.006
-
Enterovirus D68-Associated Acute Respiratory Illness - New Vaccine Surveillance Network, United States, July-November 2018-2020. MMWR Morb Mortal Wkly Rep. 2021 Nov 26; 70(47):1623-1628.
Score: 0.006
-
Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12-18 Years - United States, June-September 2021. MMWR Morb Mortal Wkly Rep. 2021 Oct 22; 70(42):1483-1488.
Score: 0.006
-
Understanding Vaccine Hesitancy Among Parents of Children With Autism Spectrum Disorder and Parents of Children With Non-Autism Developmental Delays. J Child Neurol. 2021 09; 36(10):911-918.
Score: 0.006
-
Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children: Multicenter Surveillance, United States, January-March 2020. J Pediatric Infect Dis Soc. 2020 Nov 10; 9(5):609-612.
Score: 0.005
-
Index of suspicion. Case #1. Diagnosis: juvenile dermatomyositis (JDM). Pediatr Rev. 2000 Nov; 21(11):389-92.
Score: 0.005
-
Vaccine Effectiveness Against Pediatric Influenza Hospitalizations and Emergency Visits. Pediatrics. 2020 11; 146(5).
Score: 0.005
-
Respiratory Syncytial Virus-Associated Hospitalizations Among Young Children: 2015-2016. Pediatrics. 2020 07; 146(1).
Score: 0.005
-
Evidence for Household Transmission of Rotavirus in the United States, 2011-2016. J Pediatric Infect Dis Soc. 2020 Apr 30; 9(2):181-187.
Score: 0.005
-
Mining HPV Vaccine Knowledge Structures of Young Adults From Reddit Using Distributional Semantics and Pathfinder Networks. Cancer Control. 2020 Jan-Dec; 27(1):1073274819891442.
Score: 0.005
-
Association of Rotavirus Vaccination With Inpatient and Emergency Department Visits Among Children Seeking Care for Acute Gastroenteritis, 2010-2016. JAMA Netw Open. 2019 09 04; 2(9):e1912242.
Score: 0.005
-
Enterovirus D68-Associated Acute Respiratory Illness - New Vaccine Surveillance Network, United States, July-October, 2017 and 2018. MMWR Morb Mortal Wkly Rep. 2019 Mar 29; 68(12):277-280.
Score: 0.005
-
Factors Associated With Rotavirus Vaccine Coverage. Pediatrics. 2019 02; 143(2).
Score: 0.005
-
Early Usability Assessment of a Conversational Agent for HPV Vaccination. Stud Health Technol Inform. 2019; 257:17-23.
Score: 0.005
-
Rotavirus Strain Trends During the Postlicensure Vaccine Era: United States, 2008-2013. J Infect Dis. 2016 09 01; 214(5):732-8.
Score: 0.004
-
Epidemiologic Association Between FUT2 Secretor Status and Severe Rotavirus Gastroenteritis in Children in the United States. JAMA Pediatr. 2015 Nov; 169(11):1040-5.
Score: 0.004
-
Long-term Consistency in Rotavirus Vaccine Protection: RV5 and RV1 Vaccine Effectiveness in US Children, 2012-2013. Clin Infect Dis. 2015 Dec 15; 61(12):1792-9.
Score: 0.004
-
Innate Susceptibility to Norovirus Infections Influenced by FUT2 Genotype in a United States Pediatric Population. Clin Infect Dis. 2015 Jun 01; 60(11):1631-8.
Score: 0.004
-
Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011. Clin Infect Dis. 2013 Jul; 57(1):13-20.
Score: 0.003
-
Detection of rotavirus antigenemia in routinely obtained serum specimens to augment surveillance and vaccine effectiveness evaluations. Pediatr Infect Dis J. 2010 Sep; 29(9):836-9.
Score: 0.003